Treatments for Alzheimer’s, finally

Amazon reported accelerated cloud growth in the quarter to the end of June, and JPMorgan has walked into another football firestorm as it works on a plan with Fifa. Plus, Citadel bought Situational Awareness equity holdings after the hedge fund suffered steep AI losses, and DR Co ...  Show more

Meta and Microsoft reported quarterly earnings as investors raised concerns about AI spending, and the US Federal Reserve held interest rates steady. The Bank of Japan is also expected to leave rates unchanged at its meeting on Friday, and UK oil and gas companies are looking awa ...  Show more

The former prime minister says it’s his “happiest day” as president of Alzheimer’s Research UK, after the discovery of the first drug to slow the disease.He also speaks about whether he did enough during his premiership to support those who needed dementia care.And, the BBC’s hea ...  Show more

Last year, researchers announced that the Alzheimer’s drug lecanemab lowered the amount of amyloid protein plaques associated with the disease in the brains of participants in a clinical trial, and slowed their cognitive decline.Now, researchers are looking to drug combinations, ...  Show more

Just before the pandemic, the government promised a 'dementia moonshot' to blast us towards a dementia cure. What happened to it?Today: former prime minister David Cameron and Sunday Times science editor Ben Spencer on Britain’s fastest growing disease, dementia.This podcast was ...  Show more

Elizabeth Holmes goes to prison, the Sackler family escapes liability, and Twitter's valuation drops even lower. Also, Congress votes to raise the debt ceiling, but did Speaker McCarthy get floored? Leading AI scientists and entrepreneurs warn of possible extinction. Kara and Sco ...  Show more